Key terms
About NBY
NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase, CelleRx, and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest NBY news
Mar 13
7:28am ET
NovaBay, Eyenovia to co-promote prescription ophthalmic products
Feb 01
11:24am ET
Biotech Alert: Searches spiking for these stocks today
Jan 31
10:56am ET
Biotech Alert: Searches spiking for these stocks today
Jan 12
11:36am ET
Biotech Alert: Searches spiking for these stocks today
Jan 11
11:25am ET
Biotech Alert: Searches spiking for these stocks today
Jan 11
11:25am ET
Biotech Alert: Searches spiking for these stocks today
Jan 09
9:21am ET
NovaBay, Sonoma Pharmaceuticals to market Avenova-branded products in EU
Jan 09
9:17am ET
Sonoma Pharmaceuticals, NovaBay enter sales, marketing agreement
No recent news articles are available for NBY
No recent press releases are available for NBY
NBY Financials
Key terms
Ad Feedback
NBY Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
NBY Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range